Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kiniksa Pharmaceuticals International (KNSA) Cash from Investing Activities (2021 - 2025)

Kiniksa Pharmaceuticals International's Cash from Investing Activities history spans 5 years, with the latest figure at -$70.8 million for Q4 2025.

  • For Q4 2025, Cash from Investing Activities fell 208.46% year-over-year to -$70.8 million; the TTM value through Dec 2025 reached -$189.0 million, down 601.68%, while the annual FY2025 figure was -$189.0 million, 601.68% down from the prior year.
  • Cash from Investing Activities reached -$70.8 million in Q4 2025 per KNSA's latest filing, down from -$62.8 million in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $86.0 million in Q2 2021 to a low of -$70.8 million in Q4 2025.
  • Average Cash from Investing Activities over 5 years is -$3.0 million, with a median of -$9.3 million recorded in 2023.
  • Peak YoY movement for Cash from Investing Activities: surged 538.38% in 2024, then tumbled 888.58% in 2025.
  • A 5-year view of Cash from Investing Activities shows it stood at -$50.0 million in 2021, then grew by 14.75% to -$42.7 million in 2022, then soared by 65.09% to -$14.9 million in 2023, then soared by 538.38% to $65.3 million in 2024, then tumbled by 208.46% to -$70.8 million in 2025.
  • Per Business Quant, the three most recent readings for KNSA's Cash from Investing Activities are -$70.8 million (Q4 2025), -$62.8 million (Q3 2025), and -$3.9 million (Q2 2025).